FSUS:LSE:LSE-iShares Edge MSCI USA Multifactor UCITS (GBX)

ETF | Others |

Last Closing

USD 933.125

Change

+1.50 (+0.16)%

Market Cap

N/A

Volume

180.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-3.05 (-1.64%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.19 (-0.98%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.45%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

-3.55 (-3.26%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.25 (-0.78%)

USD 259.48B
0QZO:LSE 0QZO

-1.10 (-1.21%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-0.40 (-0.27%)

USD 202.26B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing FSUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.64% 17% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.64% 17% F 25% F
Trailing 12 Months  
Capital Gain 5.04% 57% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.04% 51% F 57% F
Trailing 5 Years  
Capital Gain 77.40% 71% C- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.40% 68% D+ 73% C
Average Annual (5 Year Horizon)  
Capital Gain 12.82% 75% C 76% C+
Dividend Return 12.82% 74% C 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.33% 63% D 79% B-
Risk Adjusted Return 124.06% 97% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike